Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:ABBVNASDAQ:AVGONYSE:PG On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeABBVAbbVie$189.50-0.7%$187.37$163.81▼$218.66$334.34B0.486.25 million shs3.71 million shsAVGOBroadcom$274.87+1.8%$238.77$128.50▼$277.71$1.29T1.1228.58 million shs10.59 million shsPGProcter & Gamble$160.72-0.3%$162.10$156.58▼$180.43$377.07B0.47.49 million shs7.00 million shsTen Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceABBVAbbVie0.00%+4.19%+1.18%+1.57%+15.66%AVGOBroadcom0.00%+2.05%+5.75%+87.89%+58.95%PGProcter & Gamble0.00%+0.46%-1.17%-1.84%-1.85%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationABBVAbbVie4.9049 of 5 stars3.45.03.33.92.81.71.3AVGOBroadcom4.8275 of 5 stars2.55.02.53.23.62.51.9PGProcter & Gamble4.9156 of 5 stars3.45.04.21.73.62.51.3Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceABBVAbbVie 2.81Moderate Buy$211.2911.50% UpsideAVGOBroadcom 3.03Buy$281.462.40% UpsidePGProcter & Gamble 2.78Moderate Buy$178.4511.03% UpsideCurrent Analyst Ratings BreakdownLatest AVGO, PG, and ABBV Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/3/2025AVGOBroadcomMizuhoSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$310.00 ➝ $315.006/24/2025AVGOBroadcomHsbc Global ResSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeHold ➝ Strong-Buy6/24/2025AVGOBroadcomHSBCSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeHold ➝ Buy$400.006/11/2025ABBVAbbVieCitigroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetHold$205.006/9/2025ABBVAbbVieBank of AmericaSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetHold$204.006/9/2025AVGOBroadcomCitigroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$276.00 ➝ $285.006/9/2025AVGOBroadcomBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$215.00 ➝ $265.006/6/2025AVGOBroadcomTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price TargetBuy ➝ Buy$267.00 ➝ $295.006/6/2025AVGOBroadcomCowenSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy6/6/2025AVGOBroadcomSusquehannaSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetPositive ➝ Positive$280.00 ➝ $300.006/6/2025AVGOBroadcomMizuhoSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$300.00 ➝ $310.00(Data available from 7/6/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookABBVAbbVie$56.33B5.94$14.94 per share12.68$1.90 per share99.74AVGOBroadcom$51.57B25.07$5.98 per share45.95$14.80 per share18.57PGProcter & Gamble$84.04B4.48$8.12 per share19.79$21.08 per share7.62Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateABBVAbbVie$4.28B$2.3580.6413.561.267.31%412.03%13.11%7/31/2025 (Estimated)AVGOBroadcom$5.90B$2.67102.9543.081.9622.64%35.49%14.58%9/4/2025 (Estimated)PGProcter & Gamble$14.88B$6.3025.5121.904.5818.46%32.67%13.45%7/29/2025 (Estimated)Latest AVGO, PG, and ABBV EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails7/29/2025Q4 2025PGProcter & Gamble$1.43N/AN/AN/A$20.79 billionN/A7/24/2025Q2 2025ABBVAbbVie$3.24N/AN/AN/A$14.93 billionN/A6/5/2025Q2 2025AVGOBroadcom$1.57$1.58+$0.01$1.03$14.98 billion$15.00 billion4/25/2025Q1 2025ABBVAbbVie$2.40$2.46+$0.06$0.72$12.91 billion$13.34 billion4/24/2025Q3 2025PGProcter & Gamble$1.53$1.54+$0.01$1.54$20.42 billion$19.78 billionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthABBVAbbVie$6.563.46%N/A279.15%53 YearsAVGOBroadcom$2.360.86%N/A88.39%15 YearsPGProcter & Gamble$4.232.63%N/A67.14%70 YearsLatest AVGO, PG, and ABBV DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date6/20/2025ABBVAbbViequarterly$1.643.54%7/15/20257/15/20258/15/20256/4/2025AVGOBroadcomquarterly$0.590.91%6/20/20256/20/20256/30/20254/8/2025PGProcter & Gamblequarterly$1.05682.68%4/21/20254/21/20255/15/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioABBVAbbVie44.140.760.64AVGOBroadcom0.891.080.98PGProcter & Gamble0.470.710.50Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipABBVAbbVie70.23%AVGOBroadcom76.43%PGProcter & Gamble65.77%Insider OwnershipCompanyInsider OwnershipABBVAbbVie0.25%AVGOBroadcom2.00%PGProcter & Gamble0.18%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableABBVAbbVie55,0001.77 billion1.76 billionOptionableAVGOBroadcom37,0004.70 billion4.61 billionOptionablePGProcter & Gamble108,0002.34 billion2.34 billionOptionableAVGO, PG, and ABBV HeadlinesRecent News About These CompaniesJim Cramer on Procter & Gamble: “They’ll Be Able to Beat the Numbers”July 5 at 11:43 AM | insidermonkey.comThese 3 Amazing Dividend Stocks Have Rewarded Shareholders ForeverJuly 5 at 10:25 AM | 247wallst.comBurke & Herbert Bank & Trust Co. Sells 2,692 Shares of Procter & Gamble Company (The) (NYSE:PG)July 5 at 9:01 AM | marketbeat.comSutton Place Investors LLC Has $216,000 Stock Position in Procter & Gamble Company (The) (NYSE:PG)July 5 at 9:01 AM | marketbeat.comConcurrent Investment Advisors LLC Acquires 25,059 Shares of Procter & Gamble Company (The) (NYSE:PG)July 5 at 8:41 AM | marketbeat.comBraun Stacey Associates Inc. Acquires 2,445 Shares of Procter & Gamble Company (The) (NYSE:PG)July 5 at 8:41 AM | marketbeat.comProcter & Gamble Company (The) (NYSE:PG) Shares Sold by HM Payson & Co.July 5 at 8:32 AM | marketbeat.comDT Investment Partners LLC Sells 4,819 Shares of Procter & Gamble Company (The) (NYSE:PG)July 5 at 8:32 AM | marketbeat.comBank of New York Mellon Corp Has $3.21 Billion Stock Holdings in Procter & Gamble Company (The) (NYSE:PG)July 5 at 8:25 AM | marketbeat.comWorld Investment Advisors Increases Stake in Procter & Gamble Company (The) (NYSE:PG)July 5 at 8:11 AM | marketbeat.comGenerali Investments CEE investicni spolecnost a.s. Sells 2,359 Shares of Procter & Gamble Company (The) (NYSE:PG)July 5 at 8:10 AM | marketbeat.comJackson Thornton Wealth Management LLC Buys 1,889 Shares of Procter & Gamble Company (The) (NYSE:PG)July 5 at 7:57 AM | marketbeat.comTruist Financial Corp Cuts Stake in Procter & Gamble Company (The) (NYSE:PG)July 5 at 7:36 AM | marketbeat.comProcter & Gamble Company (The) (NYSE:PG) Shares Bought by Capital Investment Advisory Services LLCJuly 5 at 7:16 AM | marketbeat.comImpax Asset Management Group plc Sells 57,740 Shares of Procter & Gamble Company (The) (NYSE:PG)July 5 at 6:53 AM | marketbeat.comPG - Procter & Gamble Co Price vs Fair Value | MorningstarJuly 5 at 5:18 AM | morningstar.comMStrategic Blueprint LLC Sells 6,837 Shares of Procter & Gamble Company (The) (NYSE:PG)July 4 at 8:48 AM | marketbeat.comKintegral Advisory LLC Trims Position in Procter & Gamble Company (The) (NYSE:PG)July 4 at 8:38 AM | marketbeat.comNichols & Pratt Advisers LLP MA Has $63.44 Million Holdings in Procter & Gamble Company (The) (NYSE:PG)July 4 at 8:29 AM | marketbeat.comProcter & Gamble Company (The) (NYSE:PG) Shares Purchased by IFM Investors Pty LtdJuly 4 at 8:03 AM | marketbeat.comProcter & Gamble Company (The) (NYSE:PG) Shares Bought by OneDigital Investment Advisors LLCJuly 4 at 7:46 AM | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All Headlines3 Semiconductor Stocks Poised to Surge on AI SpendingBy Chris Markoch | June 25, 2025View 3 Semiconductor Stocks Poised to Surge on AI Spending3 Stocks Getting Rare Double Upgrades From AnalystsBy Chris Markoch | June 6, 2025View 3 Stocks Getting Rare Double Upgrades From AnalystsDollar Down 10%? These 3 Stocks Could SoarBy Chris Markoch | July 1, 2025View Dollar Down 10%? These 3 Stocks Could SoarAnalyst Sees Meta Hitting $800: What May Lead Shares to New HighsBy Leo Miller | June 24, 2025View Analyst Sees Meta Hitting $800: What May Lead Shares to New Highs3 Summer Stocks With Insider Buying and Analyst SupportBy Chris Markoch | June 12, 2025View 3 Summer Stocks With Insider Buying and Analyst SupportAVGO, PG, and ABBV Company DescriptionsAbbVie NYSE:ABBV$189.50 -1.25 (-0.66%) Closing price 07/3/2025 03:58 PM EasternExtended Trading$188.90 -0.60 (-0.32%) As of 07/3/2025 04:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, ulcerative colitis, and Crohn's disease; Imbruvica for the treatment of adult patients with blood cancers; Epkinly to treat lymphoma; Elahere to treat cancer; and Venclexta/Venclyxto to treat blood cancers. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; botox therapeutic; Vraylar for depressive disorder; Duopa and Duodopa to treat advanced Parkinson's disease; Ubrelvy for the acute treatment of migraine in adults; and Qulipta for episodic and chronic migraine. In addition, the company offers Ozurdex for eye diseases; Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension; Restasis to increase tear production; and other eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus genotype 1-6 infection; Creon, a pancreatic enzyme therapy; Lupron to treat advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; and Synthroid for hypothyroidism. It has collaborations with Calico Life Sciences LLC; REGENXBIO Inc.; Janssen Biotech, Inc.; and Genentech, Inc., as well as collaboration with Tentarix Biotherapeutics, LP to develop conditionally-active and multi-specific biologics for oncology and immunology. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.Broadcom NASDAQ:AVGO$274.86 +4.97 (+1.84%) Closing price 07/3/2025 03:58 PM EasternExtended Trading$275.38 +0.51 (+0.19%) As of 07/3/2025 04:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Broadcom Inc. designs, develops, and supplies various semiconductor devices with a focus on complex digital and mixed signal complementary metal oxide semiconductor based devices and analog III-V based products worldwide. The company operates in two segments, Semiconductor Solutions and Infrastructure Software. It provides set-top box system-on-chips (SoCs); cable, digital subscriber line, and passive optical networking central office/consumer premise equipment SoCs; wireless local area network access point SoCs; Ethernet switching and routing custom silicon solutions; serializer/deserializer application specific integrated circuits; optical and copper, and physical layer devices; and fiber optic components and RF semiconductor devices. The company also offers RF front end modules and filter; Wi-Fi, Bluetooth, and global positioning system/global navigation satellite system SoCs; custom touch controllers; inductive charging; attached small computer system interface, and redundant array of independent disks controllers and adapters; peripheral component interconnect express; fiber channel host bus adapters; read channel based SoCs; custom flash controllers; preamplifiers; optocouplers, industrial fiber optics, and motion control encoders and subsystems; light emitting diode, ethernet PHYs, switch ICs, and camera microcontrollers. Its products are used in various applications, including enterprise and data center networking, home connectivity, set-top boxes, broadband access, telecommunication equipment, smartphones and base stations, data center servers and storage systems, factory automation, power generation and alternative energy systems, and electronic displays. Broadcom Inc. was founded in 1961 and is headquartered in Palo Alto, California.Procter & Gamble NYSE:PG$160.72 -0.48 (-0.30%) Closing price 07/3/2025 03:59 PM EasternExtended Trading$160.74 +0.01 (+0.01%) As of 07/3/2025 04:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Procter & Gamble Co. engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances. The Health Care segment includes oral care products like toothbrushes, toothpaste, and personal health care such as gastrointestinal, rapid diagnostics, respiratory, and vitamins, minerals, and supplements. The Fabric and Home care segment consists of fabric enhancers, laundry additives and detergents, and air, dish, and surface care. The Baby, Feminine and Family Care segment sells baby wipes, diapers, and pants, adult incontinence, feminine care, paper towels, tissues, and toilet paper. The company was founded by William Procter and James Gamble in 1837 and is headquartered in Cincinnati, OH. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 06/30 - 07/04 The Apple Comeback Will Be Better Than the Setback Micron’s Big Q3 Drives Applied Materials’ Bullish Outlook Why Occidental's Price Dip Signals a Buying Opportunity Qualcomm’s Hold Rating Misses Strong Growth Story Rigetti Computing: Cantor's Bullish Call May Be Just the Start Insider Selling at NVIDIA Could Turn Into an Opportunity Whiplash for Investors: AeroVironment's Confusing Stock Signals Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
